Home > Income Statement > CORONA REMEDIES

CORONA REMEDIES
Operating Profit

    Back to Income Statement
CORONA REMEDIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Operating Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Operating Profit (Excl OI) ₹240 Cr₹1,547 Cr₹128 Cr₹128 Cr

What is the latest Operating Profit of CORONA REMEDIES ?

The latest Operating Profit ratio of CORONA REMEDIES is ₹240 Cr based on Mar2026 Consolidated results.
Year Operating Profit
Mar2026₹240 Cr
Mar2025₹1,547 Cr
Mar2024₹128 Cr
Mar2023₹128 Cr

How is Operating Profit of CORONA REMEDIES Trending?

Years Operating Profit % Change
Mar2026 ₹240 Cr
-84.49
Mar2025 ₹1,547 Cr
1,109.05
Mar2024 ₹128 Cr
0.00
Mar2023 ₹128 Cr -

Compare Operating Profit of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,651.6 Cr 2.3% 19.5% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr 0.7% 8.1% 16% Stock Analytics
DIVIS LABORATORIES ₹194,316.0 Cr 7% 10.2% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,316.0 Cr 2.5% 11.3% 49.6% Stock Analytics
CIPLA ₹115,477.0 Cr -0.3% 4.1% -3.3% Stock Analytics
DR REDDYS LABORATORIES ₹102,156.0 Cr -3.2% -3.9% -3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

2.3%

19.5%

NA
SENSEX

0.9%

2.2%

-7.5%


You may also like the below Video Courses